Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.

[1]  R. Humphries,et al.  Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2 , 2019, The Journal of antimicrobial chemotherapy.

[2]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[3]  S. Pongolini,et al.  In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment , 2018, The Journal of antimicrobial chemotherapy.

[4]  Stephania Stump,et al.  Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates , 2017, Antimicrobial Agents and Chemotherapy.

[5]  Brad Spellberg,et al.  Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering , 2017, mBio.

[6]  M. Christner,et al.  Emergence of ceftazidime/avibactam non‐susceptibility in an MDR Klebsiella pneumoniae isolate , 2017, The Journal of antimicrobial chemotherapy.

[7]  B. Kreiswirth,et al.  Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature , 2017, Open forum infectious diseases.

[8]  M. Ye,et al.  High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae , 2017, The Journal of antimicrobial chemotherapy.

[9]  M. Arthur,et al.  Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase , 2017, Antimicrobial Agents and Chemotherapy.

[10]  Hongwei Zhou,et al.  Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China , 2017, EBioMedicine.

[11]  Xiaoling Ma,et al.  Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae , 2017, Annals of Clinical Microbiology and Antimicrobials.

[12]  B. Kreiswirth,et al.  In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases , 2017, Antimicrobial Agents and Chemotherapy.

[13]  R. Bonomo,et al.  Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop. , 2015, The Journal of antimicrobial chemotherapy.

[14]  D. Ehmann,et al.  Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases , 2013, The Journal of Biological Chemistry.

[15]  Y. Qi,et al.  ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. , 2011, The Journal of antimicrobial chemotherapy.